Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 612,500 | reported | 07 Mar 2008 | tx 12+1,104,300 |
| RenovoRx, Inc. | 47,640 | reported | 01 Oct 2025 | tx 6+138,673 |
| Quince Therapeutics, Inc. | 27,000 | reported | 04 Jun 2025 | tx 7+132,933 |
| ALBANY MOLECULAR RESEARCH INC | 0 | reported | 10 May 2017 | tx 42+157,689−13,498 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Oct 2025 | GRANT_AWARD | RenovoRx, Inc. | 47,640 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 01 Oct 2024 | GRANT_AWARD | RenovoRx, Inc. | 25,099 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 01 Oct 2023 | GRANT_AWARD | RenovoRx, Inc. | 25,099 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 01 Oct 2022 | GRANT_AWARD | RenovoRx, Inc. | 25,099 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 10 Mar 2022 | GRANT_AWARD | RenovoRx, Inc. | 4,582 | 0.00 USD | deriv |
| 01 Oct 2021 | GRANT_AWARD | RenovoRx, Inc. | 11,154 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Quince Therapeutics, Inc. | 11,029 | 0.00 USD | deriv |
| 08 Jun 2020 | GRANT_AWARD | Quince Therapeutics, Inc. | 11,029 | 0.00 USD | deriv |
| 13 May 2019 | PURCHASE | Quince Therapeutics, Inc. | 2,875 | 17.00 USD | first after silence |
| 10 May 2017 | EXERCISE | ALBANY MOLECULAR RESEARCH INC | 5,000 | 14.47 USD | |
| 10 May 2017 | EXERCISE | ALBANY MOLECULAR RESEARCH INC | 5,000 | 14.47 USD | deriv |
| 08 Feb 2017 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 3,802 | 0.00 USD | |
| 08 Feb 2017 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 9,358 | 0.00 USD | deriv |
| 05 Oct 2016 | EXERCISE | ALBANY MOLECULAR RESEARCH INC | 5,000 | 11.83 USD | |
| 05 Oct 2016 | TAX_WITHHOLDING | ALBANY MOLECULAR RESEARCH INC | 3,498 | 16.91 USD | |
| 05 Oct 2016 | EXERCISE | ALBANY MOLECULAR RESEARCH INC | 5,000 | 11.83 USD | deriv |
| 15 Jun 2016 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 4,048 | 14.82 USD | |
| 04 Feb 2016 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 2,854 | 15.77 USD | |
| 04 Feb 2016 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 6,540 | 15.77 USD | deriv |
| 12 Jun 2015 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 1,126 | 19.98 USD | |
| 02 Mar 2015 | GRANT_AWARD | ALBANY MOLECULAR RESEARCH INC | 2,639 | 17.05 USD |
3 purchases reported after at least 12 months of silence — most recent on 13 May 2019.